Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones

Bioorg Med Chem. 2014 Nov 15;22(22):6422-9. doi: 10.1016/j.bmc.2014.09.044. Epub 2014 Oct 2.

Abstract

Myeloperoxidase (MPO) produces hypohalous acids as a key component of the innate immune response; however, release of these acids extracellularly results in inflammatory cell and tissue damage. The two-step, one-pot Davis-Beirut reaction was used to synthesize a library of 2H-indazoles and 1H-indazolones as putative inhibitors of MPO. A structure-activity relationship study was undertaken wherein compounds were evaluated utilizing taurine-chloramine and MPO-mediated H2O2 consumption assays. Docking studies as well as toxicophore and Lipinski analyses were performed. Fourteen compounds were found to be potent inhibitors with IC50 values <1μM, suggesting these compounds could be considered as potential modulators of pro-oxidative tissue injury pertubated by the inflammatory MPO/H2O2/HOCl/HOBr system.

Keywords: 2H-Indazole; Computational docking; Davis–Beirut reaction; Myeloperoxidase; Structure–activity relationship.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Binding Sites
  • Catalytic Domain
  • Chloramines / chemistry
  • Chloramines / metabolism
  • Humans
  • Indazoles / chemistry*
  • Indazoles / metabolism
  • Molecular Docking Simulation
  • Peroxidase / antagonists & inhibitors*
  • Peroxidase / metabolism
  • Protein Binding
  • Structure-Activity Relationship
  • Taurine / chemistry
  • Taurine / metabolism

Substances

  • Chloramines
  • Indazoles
  • Taurine
  • Peroxidase
  • chloramine